Antonis Kokkalis

Years Active: 2019-2022
Publications (10 Years): 3

Dana Farber Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dana Farber Cancer Institute Aug 29 2016

United States

Postdoctoral Research Fellow :: Medical Oncology

Publications

Johannes M Waldschmidt, Andrew J Yee, Tushara Vijaykumar, Ricardo A Pinto, Julia Frede, Praveen Anand, Giada Bianchi, Guangwu Guo, Sayalee Potdar, Charles Seifer, Monica S Nair, Antonis Kokkalis, Jake A Kloeber, Samantha Shapiro, Lillian Budano, Mason Mann, Robb Friedman, Brea Lipe, Erica Campagnaro, Elizabeth K O'Donnell, Cheng-Zhong Zhang, Jacob P Laubach, Nikhil C Munshi, Paul Gerard Richardson, Kenneth C Anderson, Noopur S Raje, Birgit Knoechel, Jens G Lohr
Cell-free DNA for the detection of emerging treatment failure in relapsed/ refractory multiple myeloma. Leukemia 36 (4) (2022)
Julia Frede, Praveen Anand, Noori Sotudeh, Ricardo A Pinto, Monica S Nair, Hannah Stuart, Andrew J Yee, Tushara Vijaykumar, Johannes M Waldschmidt, Sayalee Potdar, Jake A Kloeber, Antonis Kokkalis, Valeriya Dimitrova, Mason Mann, Jacob P Laubach, Paul G Richardson, Kenneth C Anderson, Noopur S Raje, Birgit Knoechel, Jens G Lohr
Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma. Nature cell biology 23 (11) (2021)
Evangelia Chavdoula, David M Habiel, Eugenia Roupakia, Georgios S Markopoulos, Eleni Vasilaki, Antonis Kokkalis, Alexander P Polyzos, Haralabia Boleti, Dimitris Thanos, Apostolos Klinakis, Evangelos Kolettas, Kenneth B Marcu
CHUK/IKK-α loss in lung epithelial cells enhances NSCLC growth associated with HIF up-regulation. Life science alliance 2 (6) (2019)

Antonis Kokkalis.css-eqlu8i{font-size:small;padding-left:4px;}